The impact of antimicrobial-resistant, health care-associated infections on mortality in the United States.
about
Effectiveness of Practices To Increase Timeliness of Providing Targeted Therapy for Inpatients with Bloodstream Infections: a Laboratory Medicine Best Practices Systematic Review and Meta-analysisWill there ever be a universal Staphylococcus aureus vaccine?Contribution of coagulases towards Staphylococcus aureus disease and protective immunityCrystal structure of the enzyme CapF of Staphylococcus aureus reveals a unique architecture composed of two functional domainsSecreted Proteases Control Autolysin-mediated Biofilm Growth of Staphylococcus aureusExpression, purification, crystallization and preliminary X-ray analysis of the PaaI-like thioesterase SAV0944 fromStaphylococcus aureusMining the bacterial unknown proteome: identification and characterization of a novel family of highly conserved protective antigens in Staphylococcus aureusStaphylococcus aureus in the Intensive Care Unit: Are These Golden Grapes Ripe for a New Approach?Preventing Staphylococcus aureus sepsis through the inhibition of its agglutination in blood.Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice.Antiinfective therapy with a small molecule inhibitor of Staphylococcus aureus sortase.State-Mandated Hospital Infection Reporting Is Not Associated With Decreased Pediatric Health Care-Associated InfectionsLong-term survival and healthcare utilization outcomes attributable to sepsis and pneumonia.Small molecule inhibitor of lipoteichoic acid synthesis is an antibiotic for Gram-positive bacteria.A play in four acts: Staphylococcus aureus abscess formationExcess mortality and long-term disability from healthcare-associated staphylococcus aureus infections: a population-based matched cohort studyProtein A suppresses immune responses during Staphylococcus aureus bloodstream infection in guinea pigs.LytN, a murein hydrolase in the cross-wall compartment of Staphylococcus aureus, is involved in proper bacterial growth and envelope assembly.Evaluation of the antibacterial activity of the Althaea officinalis L. leaf extract and its wound healing potency in the rat model of excision wound creation.Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infections.Monoclonal Antibody Targeting Staphylococcus aureus Surface Protein A (SasA) Protect Against Staphylococcus aureus Sepsis and Peritonitis in Mice.Outcomes of high-dose levofloxacin therapy remain bound to the levofloxacin minimum inhibitory concentration in complicated urinary tract infections.Abscess formation and alpha-hemolysin induced toxicity in a mouse model of Staphylococcus aureus peritoneal infection.Coagulases as determinants of protective immune responses against Staphylococcus aureus.Protein A-specific monoclonal antibodies and prevention of Staphylococcus aureus disease in mice.Implementation of an antimicrobial stewardship program on the medical-surgical service of a 100-bed community hospital.Natural antibodies in normal human serum inhibit Staphylococcus aureus capsular polysaccharide vaccine efficacy.Recurrent infections and immune evasion strategies of Staphylococcus aureus.ABI domain-containing proteins contribute to surface protein display and cell division in Staphylococcus aureusExploring Staphylococcus aureus pathways to disease for vaccine development.Intermittent self catheterisation with hydrophilic, gel reservoir, and non-coated catheters: a systematic review and cost effectiveness analysisPeptidoglycan-linked protein A promotes T cell-dependent antibody expansion during Staphylococcus aureus infectionRole of protein A in the evasion of host adaptive immune responses by Staphylococcus aureus.Systematic review and meta-analysis of antimicrobial treatment effect estimation in complicated urinary tract infection.Pathogenesis of Staphylococcus aureus Bloodstream Infections.A Retrospective Study of the Impact of Rapid Diagnostic Testing on Time to Pathogen Identification and Antibiotic Use for Children with Positive Blood Cultures.Comparison of 3 real-time, quantitative murine models of staphylococcal biofilm infection by using in vivo bioluminescent imagingThe giant protein Ebh is a determinant of Staphylococcus aureus cell size and complement resistance.Changes in the incidences of multidrug-resistant and extensively drug-resistant organisms isolated in a military medical center.Antibiotic Dosing in Patients With Acute Kidney Injury: "Enough But Not Too Much".
P2860
Q26776404-5FBC7A2C-B24D-43AE-94B5-5E51CBF9E76AQ26824837-02889767-EF42-4512-A989-FE31ED45C1DFQ27313924-37072123-7048-4AD0-ADAE-043D222EDE89Q27677173-19B23455-F07F-434F-8FAF-E7CF930929B4Q27679788-295DC7A8-4BE3-4F07-ACE2-16149FDFF05EQ27682270-5D55D0E8-CEDA-4E59-8A1A-7CF5AEA0CF4EQ27685283-5664AC9C-DC42-4CFA-B3C2-36CA68BD3BA2Q30239977-8834F09C-E59A-46DC-BC9B-63D40D166894Q34058113-E1A3AC5D-FD1F-4D19-B917-89D973510CF0Q34096536-86C0C95D-8912-43BB-86FA-898D934C726EQ34218098-F37B8C5A-2596-4B2C-809D-1E21BCA51127Q34255748-B013A679-9636-4EB0-8F43-B47E60589767Q34488701-242B4690-BA7B-4DBB-BDBF-C50FA13CFA6AQ34582921-D248F8C8-8623-4274-B04F-BD595E3BF1A4Q34928131-0955E42B-BE6B-4EB9-A500-84F0508F68FDQ34936692-D444A513-7CF8-4F69-8A4F-FBDFAD05EEBFQ35038206-6ADE7735-F2B5-4145-83E8-D04FF3C967F7Q35213392-D55EB60B-0F8A-4C31-8A44-5064A0C4B441Q35564383-C633F048-45A2-4223-9E08-2F634F9AD186Q35806150-14C37C42-7D65-4364-932C-68867BB64FB4Q35939497-997A9955-6B24-4B38-A783-54286F988028Q36204123-442B530B-77D6-45A9-83A7-54FF08174B5EQ36277405-0E3314D4-7821-4EE9-95EB-1C9F3DDB7974Q36277411-C3CEAA52-32FF-4ABA-B929-22F8ACD8D675Q36277427-DE1255F0-EFA3-42F2-9AE0-77E97C32F625Q36402314-B60248BB-C070-4F04-9727-6B5168CABDCDQ36486860-08C6FD59-076A-4A06-81AD-5E795A72FAB4Q36513761-C2EC72B7-270A-4F48-852C-CC53F65CC427Q36513960-2CC4EB31-5069-45F3-99F4-5FD51AE17C7BQ36516970-F940810A-72F3-431E-AE38-63FEBF0B6B9BQ36522155-3237FB40-B2EB-4570-B80F-2F4F6C46FE31Q36930930-92681F26-A053-4901-9073-0A595DBFC911Q37140096-759B966A-CAE2-46A9-9F05-81AB21D0E622Q37263472-CA280453-4D87-4BD5-A49E-2B7524F74ADBQ37347046-7E4D9FA2-7E41-48DB-8706-E97D639D822CQ37444795-76C1944F-132E-4F30-9694-FFFA63ED4721Q37593295-4CD6436B-A67A-4657-9234-0003E5AF5DAEQ37643393-2454D85F-CE0B-4F5E-A751-6ACFE27833ECQ37760510-597D4C1A-C9BF-45F8-9F55-6178B322A366Q38261172-3EEFA485-4D21-42DA-8A29-1C9F644A030B
P2860
The impact of antimicrobial-resistant, health care-associated infections on mortality in the United States.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
The impact of antimicrobial-re ...... ortality in the United States.
@en
The impact of antimicrobial-re ...... ortality in the United States.
@nl
type
label
The impact of antimicrobial-re ...... ortality in the United States.
@en
The impact of antimicrobial-re ...... ortality in the United States.
@nl
prefLabel
The impact of antimicrobial-re ...... ortality in the United States.
@en
The impact of antimicrobial-re ...... ortality in the United States.
@nl
P2093
P2860
P356
P1476
The impact of antimicrobial-re ...... ortality in the United States.
@en
P2093
Jonathan R Edwards
National Nosocomial Infections Surveillance System
R Monina Klevens
R P Gaynes
P2860
P304
P356
10.1086/591698
P407
P577
2008-10-01T00:00:00Z